Amyris closes acquisition of menolabs

Emeryville, calif. , march 11, 2022 /prnewswire/ -- amyris, inc. (nasdaq: amrs), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its lab-to-market™ technology platform today announced that it has closed the acquisition of the assets of menolabs, llc, a company founded by women to treat menopause symptoms, drive research for women's health and improve society's understanding of menopause.
AMRS Ratings Summary
AMRS Quant Ranking